missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Descrizione
Gibco™ Chromosome Medium 1A is a complete medium for the culture of lymphocytes isolated from bone marrow for cytogenetic studies. Lymphocytes from peripheral blood can also be cultured in Gibco™ Chromosome Medium 1A, with the addition of phytohemagglutinin (PHA). The complete formulation is available.
Product Use
For Research Use Only. Not for use in diagnostic procedures.
cGMP Manufacturing and Quality System
Gibco™ Chromosome Medium 1A is manufactured at a cGMP compliant facility, located in Paisley, Scotland, UK. The facility is registered with the FDA as a medical device manufacturer and is certified to the ISO 13485 standard.
Product Use
For Research Use Only. Not for use in diagnostic procedures.
cGMP Manufacturing and Quality System
Gibco™ Chromosome Medium 1A is manufactured at a cGMP compliant facility, located in Paisley, Scotland, UK. The facility is registered with the FDA as a medical device manufacturer and is certified to the ISO 13485 standard.
Specifica
Specifica
| Forma | Liquid |
| Product Type | Chromosome Medium 1A |
| Da utilizzare con (applicazione) | Cell viability, proliferation and function, clinical and translational research, mammalian cell culture |
| Quantità | 100 mL |
| Certificazione/Conformità | ISO 13485 standards, FDA |
| Status giuridico | RUO |
| Content And Storage | –5 to –20°C |
| Descrizione | Chromosome Medium 1A, 100mL, Liquid Form, 24 Months Shelf Life, –5 to –20°C Storage Conditions, Used for Cell Viability, Proliferation and Function, Clinical and Translational Research, Mammalian Cell Culture |
For Research Use Only. Not for use in diagnostic procedures.
Titolo del prodotto
Facendo clic su Invia, l'utente riconosce che potrebbe essere contattato da Fisher Scientific in merito al feedback fornito in questo modulo. Non condivideremo le vostre informazioni per altri scopi. Tutte le informazioni di contatto fornite saranno conservate in conformità con la nostra Politica sulla privacy. Informativa sulla privacy.
Individuate un'opportunità di miglioramento?